Table of Contents Table of Contents
Previous Page  1327 / 1416 Next Page
Information
Show Menu
Previous Page 1327 / 1416 Next Page
Page Background

How important is mid-to-low dose?

1.

Reduction of secondary tumour risk

Chung et al. IJROBP. 2013 Sep 1;87(1):46-52.)